Commentary: Intraarterial Stroke Revascularization Training Guidelines

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 12, 2009, Pages 1523-1526

  Sacks, David ^a   Connors III, J J ^b  

^a READING HOSPITAL AND MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; NEW DRUG; PLACEBO; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CLINICAL PRACTICE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FIBRINOLYTIC THERAPY; HUMAN; INTERVENTIONAL RADIOLOGY; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANKIN SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STAFF TRAINING; STROKE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CLINICAL COMPETENCE; CREDENTIALING; CURRICULUM; EDUCATION, MEDICAL, GRADUATE; FIBRINOLYTIC AGENTS; HUMANS; PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; RADIOGRAPHY, INTERVENTIONAL; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 70450207092     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.10.004     Document Type: Article

References (33)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) 480-486
2. Cloft H.J., Rabinstein A., Lanzino G., and Kallmes D.F. Intra-arterial stroke therapy: an assessment of demand and available work force. AJNR Am J Neuroradiol 30 (2009) 453-458
3. Ciccone A., Sterzi R., Crespi V., Defanti C.A., and Pasetti C.f.t.B.S.G.o.t.I.N.Society. Thrombolysis for acute ischemic stroke: the patient's point of view. Cerebrovasc Dis 12 (2001) 335-340
4. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
5. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359 (2008) 1317-1329
6. Clark W.M., Wissman S., Albers G.W., Jhamandas J.H., Madden K.P., and Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours alter symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA 282 (1999) 2019-2026
7. Tomsick T., Brott T., Barsan W., et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 17 (1996) 79-85
8. Nichols C., Khoury J., Brott T., and Broderick J. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. J Stroke Cerebrovasc Dis 17 (2008) 64-68
9. Kharitonova T., Thoren M., Ahmed N., et al. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry 80 (2009) 273-278
10. Linfante I., Llinas R.H., Selim M., et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 33 (2002) 2066-2071
11. Rubiera M., Ribo M., Delgado-Mederos R., et al. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 37 (2006) 2301-2305
12. Manelfe C., Larrue V., von Kummer R., et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30 (1999) 769-772
13. Mattle H.P., Arnold M., Georgiadis D., et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 39 (2008) 379-383
14. Agarwal P., Kumar S., Hariharan S., et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?. Cerebrovasc Dis 17 (2004) 182-190
15. Furlan A.J., Higashida R.T., Wechsler L., et al. Intraarterial pro-urokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
16. Ogawa A., Mori E., Minematsu K., et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38 (2007) 2633-2639
17. Furlan AJ. The use of unproven but approved treatment and devices in stroke should be allowed. Presented at the International Stroke Conference 2009; February 19, 2009; San Diego, CA.
18. Major Ongoing Stroke Trials. Intra-arterial versus intravenous thrombolysis in acute ischemic stroke (SYNTHESIS). Stroke 37 (2006) e31
19. Ciccone A., Valvassori L., Gasparotti R., Scomazzoni F., Ballabio E., and Sterzi R. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 38 (2007) 2191-2195
20. Hirsch J.A., Yoo A.J., Nogueira R.G., et al. Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA. J Neurointerv Surg 1 (2009) 27-31
21. Lindley R.I. Is Intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?. No. Stroke 40 (2009) 2613-2614
22. Suzuki S., Saver J.L., Scott P., et al. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol 25 (2004) 1802-1806
23. White C.J., Cates C.U., Cowley M.J., et al. Interventional stroke therapy: current state of the art and needs assessment. Cathet Cardiovasc Interv 70 (2007) 471-476
24. Society of Cardiovascular and Interventional Radiology. 2000-2001 SCVIR Socioeconomics Survey (2002), SCVIR, Fairfax, VA
25. DeVries J.T., White C.J., Collins T.J., et al. Acute stroke intervention by interventional cardiologists. Cathet Cardiovasc Interv 73 (2009) 692-698
26. Heuser R.R. We are ready, willing, and able: the interventional cardiology community: but we have two hands tied behind our back. Cathet Cardiovasc Interv 73 (2009) 699-700
27. Connors III J.J., Sacks D., Black C.M., et al. Training guidelines for intra-arterial catheter-directed treatment of acute ischemic stroke: a statement from a special writing group of the Society of Interventional Radiology. J Vasc Interv Radiol 20 (2009) 1507-1522
28. Hallevi H., Barreto A.D., Liebeskind D.S., et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 40 (2009) 1780-1785
29. Meyers P.M., Schumacher H.C., Alexander M.J., et al. Performance and training standards for endovascular ischemic stroke treatment. J Neurointerv Surg 1 (2009) 10-12
30. Belisle J.G., McCollom V.E., Tytle T.L., et al. Intraarterial therapy for acute ischemic strokes. J Vasc Interv Radiol 20 (2009) 327-333
31. Emergency Interventional Stroke Therapy: A Statement from the American Society of Interventional and Therapeutic Neuroradiology Stroke Task Force of the American Society of Neuroradiology and The Society of Cardiovascular and Interventional Radiology. AJNR Am J Neuroradiol 22 (2001) 54
32. Accreditation Council for Graduate Medical Education. ACGME Outcomes Project. http://www.acgme.org/outcome/ Accessed August 12, 2009
33. Wood P.B. Competency-based training: accreditation as a pathway to wisdom. Radiology 252 (2009) 322-323